V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20031501 | 20085819 | 1.62 | 90 | Palliative (P) | 2018-12-19 | 2018-12-29 | VIDE | 02 | N | GO2 TRIAL | 100015272 |
| 20031510 | 20085820 | 1.55 | 106 | Adjuvant (A) | 2017-12-23 | 2018-01-26 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | CAPECITABINE + CETUXIMAB + IRINOTECAN | 100386721 |
| 20031514 | 20085821 | 1.68 | 92 | Palliative (P) | 2015-08-13 | 2015-08-13 | Capecitabine+Cisplatin+Streptozocin | N | N | ARISTOTLE TRIAL | 101299547 |
| 20031535 | 20085822 | 0 | 0 | 03 | 2020-01-19 | 2020-01-23 | IRINOTECAN + MDG + PANITUMUMAB | N | N | SUNITINIB | 100735105 |
| 20031545 | 20085823 | 1.63 | 112 | null | 2018-03-11 | 2018-03-12 | Pemetrexed | 02 | Y | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 100425276 |
| 20031590 | 20085824 | 1.65 | 62.2 | Adjuvant (A) | 2019-08-01 | 2019-08-16 | OXALIPLATIN | 02 | N | HYDROXYCARBAMIDE | 101152599 |
| 20031630 | 20085825 | 1.78 | 59 | Palliative (P) | 2016-06-25 | 2016-07-20 | Bendamustine+Rituximab (1st Course) | N | N | EOF | 100167904 |
| 20031683 | 20085826 | 1.87 | 86.3 | Palliative (P) | 2016-08-13 | 2016-08-20 | ACTICCA-1 Trial | 02 | null | CARBOPLATIN + DOCETAXEL | 101546661 |
| 20031718 | 20085827 | 1.61 | 103.6 | Palliative (P) | 2019-01-16 | 2019-01-29 | FOXTROT TRIAL | 02 | N | ECARBOX | 100215108 |
| 20031721 | 20085828 | 1.6 | 87.3 | 03 | 2018-08-21 | 2018-08-29 | EEF or EOF | 02 | N | DOCETAXEL | 100853552 |
| 20031756 | 20085830 | 1.63 | 103 | Palliative (P) | 2015-08-28 | 2015-08-30 | Irinotecan | 02 | N | RITUXIMAB | 100708475 |
| 20031763 | 20085831 | 1.78 | 72.4 | Adjuvant (A) | 2018-12-18 | 2019-01-03 | Hepatoblastoma SR Cisplatin | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101259930 |
| 20031786 | 20085832 | 1.57 | 67 | null | 2019-10-11 | 2019-10-11 | FOXTROT TRIAL | 02 | N | FEC + TRASTUZUMAB | 101590184 |
| 20031802 | 20085833 | 1.52 | 60.2 | 03 | 2019-07-18 | 2019-07-26 | Paclitaxel albumin (Abraxane) 21day | N | N | SCOPE 1 TRIAL | 100180577 |
| 20031821 | 20085834 | 1.56 | 95 | Adjuvant (A) | 2020-01-08 | 2020-01-08 | EOF | 02 | N | BEVACIZUMAB + IRINOTECAN + MDG | 100509916 |
| 20031937 | 20085835 | 1.56 | 9.6 | Palliative (P) | 2017-05-20 | 2017-05-27 | EVEROLIMUS | 01 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101474216 |
| 20032035 | 20085836 | 1.9 | 119 | Palliative (P) | null | 2018-04-23 | TRASTUZUMAB EMTANSINE | null | N | CABAZITAXEL | 101869235 |
| 20032091 | 20085837 | 1.56 | 94 | Adjuvant (A) | 2017-09-20 | 2017-09-20 | Bortezomib + MELPHALAN | 02 | N | SCOPE2 TRIAL | 100367326 |
| 20032098 | 20085838 | null | null | null | 2016-09-04 | 2016-09-05 | ACTICCA-1 Trial | 01 | null | GO2 TRIAL | 100651562 |
| 20032176 | 20085840 | 1.82 | 75.5 | Palliative (P) | 2017-08-15 | 2017-08-30 | Cisplatin + Fluorouracil + Streptozocin | N | N | CARBOPLATIN + FLUOROURACIL | 100601293 |
| 20032191 | 20085841 | 1.57 | 82.6 | 03 | 2016-11-14 | 2016-11-15 | VISMODEGIB | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101731124 |
| 20032245 | 20085843 | 1.65 | 67.2 | Curative (C) | 2020-10-14 | 2020-10-22 | Rituximab | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 101459748 |
| 20032339 | 20085844 | 1.62 | 106.2 | null | 2019-11-25 | 2020-01-13 | null | 02 | N | EVEROLIMUS | 100656148 |
| 20032376 | 20085845 | 1.6 | 72.3 | null | 2021-11-06 | 2021-11-27 | Raltitrexed | null | N | TRASTUZUMAB EMTANSINE | 101109098 |
| 20032390 | 20085846 | 0 | 12.6 | null | null | 2019-06-07 | BCG Intravesical | N | N | CISPLATIN + VINORELBINE | 101367265 |
| 20032394 | 20085847 | 1.59 | null | Palliative (P) | 2018-07-19 | 2018-08-01 | Bendamustine+Rituximab (1st Course) | 02 | N | DOCETAXEL | 100542438 |
| 20032412 | 20085848 | 1.73 | 91 | Palliative (P) | 2016-04-09 | 2016-04-17 | ESPAC-4 TRIAL | 02 | Y | DOCETAXEL | 101447188 |
| 20032451 | 20085849 | 1.69 | 55 | Palliative (P) | 2019-09-05 | 2019-09-09 | Carboplatin + Vinorelbine IV | 02 | N | NAB-PACLITAXEL | 100531827 |
| 20032461 | 20085850 | 1.57 | 72.9 | 03 | 2016-11-09 | 2016-12-13 | STAR TRIAL | N | N | HYDROXYCARBAMIDE | 100559201 |
| 20032527 | 20085853 | 0 | 6.4 | Palliative (P) | 2016-10-10 | 2016-10-19 | EOF | 01 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100477223 |
| 20032548 | 20085854 | 1.63 | 82.5 | 03 | 2017-07-25 | 2017-12-04 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | N | AZACITIDINE | 101413142 |
| 20032556 | 20085855 | 1.8 | 68.5 | Adjuvant (A) | 2016-01-28 | 2016-02-07 | Binimetinib + Cetuximab + Encorafenib | 02 | N | CTD | 100314680 |
| 20032585 | 20085856 | 1.64 | 73.5 | Palliative (P) | 2021-10-12 | 2021-10-30 | SCOPE 1 TRIAL | 02 | N | NIVOLUMAB | 100231228 |
| 20032626 | 20085858 | null | null | null | 2017-11-29 | 2017-12-09 | ESPAC-4 TRIAL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101198710 |
| 20032642 | 20085859 | 1.64 | 44.7 | 03 | 2022-02-23 | 2022-02-23 | IBRUTINIB | 02 | N | IRINOTECAN + MDG + PANITUMUMAB | 100478003 |
| 20032683 | 20085860 | 0 | 6.2 | Palliative (P) | 2017-09-14 | 2017-09-14 | Doxorubicin 75mg/m2 | 02 | N | CARBOPLATIN + PEMETREXED | 101127466 |
| 20032698 | 20085861 | 1.51 | 76.8 | Palliative (P) | 2019-09-19 | 2019-09-20 | CAP + RT | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 101637896 |
| 20032708 | 20085862 | 1.66 | 85.5 | Palliative (P) | 2018-08-29 | 2018-08-30 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | N | NIVOLUMAB | 100053439 |
| 20032711 | 20085863 | 1.72 | 53 | 03 | 2020-01-13 | 2020-01-31 | Chlorambucil | N | N | AZACITIDINE + VENETOCLAX | 101242406 |
| 20032721 | 20085864 | 1.62 | 75 | 03 | null | 2018-11-02 | Rituximab | N | N | GO2 TRIAL | 101242849 |
| 20032752 | 20085865 | 1.57 | 81 | null | 2016-05-04 | 2016-05-10 | FOXTROT TRIAL | 02 | N | GEMCITABINE + PACLITAXEL | 100602631 |
| 20032860 | 20085866 | 1.73 | 53.2 | Palliative (P) | null | 2017-12-11 | GEM-P | 01 | N | CAP + RT | 101339379 |
| 20032865 | 20085867 | null | 65 | null | null | 2019-12-02 | Cytarabine Low Dose | Y | N | CHLORAMBUCIL + OBINUTUZUMAB | 100963668 |
| 20032912 | 20085869 | 1.54 | 51 | Curative (C) | null | 2020-08-05 | PHITT C SIOPEL-3HR | 1 | N | CAPE + OXALIPLATIN + TRASTUZUMAB | 100455752 |
| 20032923 | 20085870 | 1.74 | 65.2 | 03 | 2019-04-09 | 2019-04-19 | ESPAC-4 TRIAL | 02 | N | CARBOPLATIN + EPIRUBICIN | 101446307 |
| 20032945 | 20085871 | 1.8 | 59.8 | Adjuvant (A) | 2016-04-11 | 2016-04-18 | Cisplatin + Docetaxel +Fluorouracil | 02 | Y | ARISTOTLE TRIAL | 101252481 |
| 20032979 | 20085872 | 1.65 | 63.2 | 03 | 2018-07-05 | 2018-07-05 | CEMIPLIMAB | 02 | N | ACTICCA-1 TRIAL | 100541733 |
| 20033069 | 20085873 | 1.66 | 80.3 | 03 | 2016-01-18 | 2016-02-08 | FOXTROT TRIAL | 02 | N | DOCETAXEL | 100068110 |
| 20033077 | 20085874 | 1.82 | 123.8 | null | 2016-08-23 | 2016-08-23 | FEC 100 | 02 | N | ESPAC TRIAL | 100124362 |
| 20033126 | 20085875 | 1.75 | 103.2 | 03 | 2019-12-10 | 2019-12-29 | Capital Trial | null | N | CAP + RT | 100325987 |